A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.
Heyland DK, van Zanten ARH, Grau-Carmona T, Evans D, Beishuizen A, Schouten J, Hoiting O, Bordejé ML, Krell K, Klein DJ, Gonzalez J, Perez A, Brown R, James J, Harris MS; Investigators of the PROMOTE LP101-CL-201 Trial.
Heyland DK, et al.
Intensive Care Med. 2019 May;45(5):647-656. doi: 10.1007/s00134-019-05593-2. Epub 2019 May 6.
Intensive Care Med. 2019.
PMID: 31062046
Free PMC article.
Clinical Trial.